Pregnant women and their babies and adults over 60 years old can be more protected from respiratory syncytial virus, or RSV, ...

Federal officials have been working with companies to find ways to boost the supply of the new vaccine for newborns.

Preventive treatment is now available for the respiratory syncytial virus, which affects 64 million people annually. But drug ...

Both shots were approved earlier this year--the first RSV vaccines after decades of unsuccessful attempts--and the third quarter was the first full quarter for which sales were reported. GSK said ...

CARMEL, In. – 18-month-old Hannah and her twin brother Nolan are full of smiles and energy, but in October of 2022 it was a ...

Respiratory syncytial virus, or RSV, is a common respiratory virus that spreads seasonally. A new drug and several vaccines that prevent the infection have recently come to market. Here's what you ...

American pharmaceutical giant filed application for regulatory approval of its Abrysvo jab in Hong Kong last month, source familiar with situation says.

EAST HARTFORD — U.S. Sen. Richard Blumenthal on Monday called for two government-approved manufacturers of the respiratory ...

Despite 50 years of research, there are currently no RSV vaccines approved or in Phase III trials for any of the target populations. High levels of neutralizing antibodies to RSV F protein have ...

Senior Biden administration officials met with RSV vaccine makers this week to underscore the need for manufacturers such as ...

CARMEL, Ind. (Ivanhoe Newswire) – Respiratory syncytial virus, or RSV, is a common illness among young kids. Eighty percent of babies catch it within their first year of life. For some, it can ...